Research Analysts’ Updated EPS Estimates for November 22nd (AAL, ANTO, AZN, BME, BREE, CBG, CDXS, CTV, DFS, DPLM)

Research Analysts’ updated eps estimates for Friday, November 22nd:

Anglo American (LON:AAL) had its neutral rating reiterated by analysts at JPMorgan Chase & Co..

Antofagasta (LON:ANTO) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co..

AstraZeneca (LON:AZN) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a £140 ($176.26) price target on the stock.

B&M European Value Retail (LON:BME) had its price target reduced by Citigroup Inc. from GBX 540 ($6.80) to GBX 510 ($6.42). Citigroup Inc. currently has a buy rating on the stock.

Breedon Group (LON:BREE) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 520 ($6.55) price target on the stock.

Breedon Group (LON:BREE) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a GBX 575 ($7.24) price target on the stock.

Close Brothers Group (LON:CBG) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 610 ($7.68) price target on the stock.

Codexis (NASDAQ:CDXS) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $11.00 target price on the stock.

Innovid (NYSE:CTV) had its hold rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $3.00 price target on the stock.

DFS Furniture (LON:DFS) had its not rated rating reiterated by analysts at Shore Capital.

Diploma (LON:DPLM) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 5,100 ($64.21) target price on the stock.

DP Poland (LON:DPP) had its not rated rating reaffirmed by analysts at Shore Capital.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 target price on the stock.

Eastman Chemical (NYSE:EMN) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $105.00 price target on the stock.

Elastic (NYSE:ESTC) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Fresnillo (LON:FRES) had its overweight rating reiterated by analysts at JPMorgan Chase & Co..

Fortinet (NASDAQ:FTNT) had its hold rating reaffirmed by analysts at Needham & Company LLC.

GAP (NYSE:GAP) had its buy rating reaffirmed by analysts at Guggenheim. The firm currently has a $35.00 price target on the stock.

Genus (LON:GNS) had its not rated rating reissued by analysts at Shore Capital.

Grainger (LON:GRI) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 336 ($4.23) price target on the stock.

Hochschild Mining (LON:HOC) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co..

Intuit (NASDAQ:INTU) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $760.00 target price on the stock.

iQIYI (NASDAQ:IQ) had its hold rating reissued by analysts at Benchmark Co..

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $200.00 target price on the stock.

JD Sports Fashion (LON:JD) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 110 ($1.38) target price on the stock.

Keros Therapeutics (NASDAQ:KROS) had its overweight rating reissued by analysts at Cantor Fitzgerald.

Korro Bio (NASDAQ:KRRO) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $115.00 price target on the stock.

LBG Media (LON:LBG) had its buy rating reaffirmed by analysts at Shore Capital.

Liontrust Asset Management (LON:LIO) had its hold rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 500 ($6.29) target price on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its hold rating reissued by analysts at Needham & Company LLC.

Masimo (NASDAQ:MASI) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $190.00 target price on the stock, up from their previous target price of $170.00.

Michelmersh Brick (LON:MBH) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 170 ($2.14) price target on the stock.

N-able (NYSE:NABL) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $16.50 target price on the stock.

Neumora Therapeutics (NASDAQ:NMRA) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $29.00 target price on the stock.

NVIDIA (NASDAQ:NVDA) had its accumulate rating reiterated by analysts at Phillip Securities. The firm currently has a $160.00 target price on the stock, up from their previous target price of $155.00.

Norcros (LON:NXR) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 375 ($4.72) target price on the stock.

Nextracker (NASDAQ:NXT) had its buy rating reiterated by analysts at Guggenheim. They currently have a $55.00 target price on the stock.

Oaktree Specialty Lending (NASDAQ:OCSL) had its market perform rating reiterated by analysts at Oppenheimer Holdings Inc.. The firm currently has a $18.00 target price on the stock.

Paycor HCM (NASDAQ:PYCR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $20.00 price target on the stock.

PayPal (NASDAQ:PYPL) had its neutral rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $88.00 target price on the stock.

PZ Cussons (LON:PZC) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 120 ($1.51) target price on the stock.

Quadrise (LON:QED) had its house stock rating reaffirmed by analysts at Shore Capital.

Roblox (NYSE:RBLX) had its strong-buy rating reissued by analysts at Raymond James. The firm currently has a $60.00 price target on the stock.

Replimune Group (NASDAQ:REPL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $17.00 price target on the stock.

Rallybio (NASDAQ:RLYB) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $5.00 target price on the stock.

Ross Stores (NASDAQ:ROST) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $180.00 price target on the stock.

J Sainsbury (LON:SBRY) had its house stock rating reaffirmed by analysts at Shore Capital.

SelectQuote (NYSE:SLQT) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $4.00 target price on the stock.

Spirent Communications (LON:SPT) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 225 ($2.83) target price on the stock.

TFS Financial (NASDAQ:TFSL) had its neutral rating reissued by analysts at Piper Sandler. The firm currently has a $15.00 target price on the stock.

Timken (NYSE:TKR) had its sector weight rating reissued by analysts at KeyCorp.

TransMedics Group (NASDAQ:TMDX) had its hold rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $109.00 target price on the stock.

Under Armour (NYSE:UAA) had its hold rating reissued by analysts at Needham & Company LLC.

Unicycive Therapeutics (NASDAQ:UNCY) had its speculative buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $3.00 target price on the stock.

USA Compression Partners (NYSE:USAC) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $27.00 price target on the stock.

VolitionRx (NYSE:VNRX) had its hold rating reaffirmed by analysts at Benchmark Co..

Warner Music Group (NASDAQ:WMG) had its buy rating reissued by analysts at Guggenheim. They currently have a $44.00 price target on the stock.

Xenetic Biosciences (NASDAQ:XBIO) had its neutral rating reiterated by analysts at HC Wainwright.

XPS Pensions Group (LON:XPS) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 435 ($5.48) target price on the stock.

Zymeworks (NYSE:ZYME) had its neutral rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $12.00 target price on the stock.